Abstract
Neuropathic pain (NeP) is commonly encountered in patients with diseases associated with spinal cord damage (e.g., spinal cord injury (SCI) and compressive myelopathy). Recent studies described persistent glial activation and neuronal hyperactivity in SCI, but the pathomechanisms of NeP in chronic compression of the spinal cord remains elusive. The purpose of the present study was to determine the roles of microglia and infiltrating macrophages in NeP. The study was conducted in chimeric spinal hyperostotic mice (ttw/ttw), characterized by chronic progressive compression of the spinal cord as a suitable model of human compressive myelopathy. The severity of spinal cord compression correlated with proportion of activated microglia and hematogenous macrophages. Spinal cord compression was associated with overexpression of mitogen-activated protein kinases (MAPKs) in infiltrating macrophages and reversible blood-spinal cord barrier (BSCB) disruption in the dorsal horns. Our results suggested that chronic neuropathic pain in long-term spinal cord compression correlates with infiltrating macrophages, activated microglial cells and the associated damage of BSCB, together with overexpression of p-38 MAPK and p-ERK1/2 in these cells. Our findings are potentially useful for the design of new therapies to alleviate chronic neuropathic pain associated with compressive myelopathy.
Similar content being viewed by others
Introduction
Neuropathic pain (NeP) represents pain associated with anatomical or functional abnormalities of the nervous system1, and is often observed in certain diseases including iatrogenic conditions affecting the somatosensory pathways in the peripheral or central nervous system2. For example, about half of patients with spinal disorders suffer from NeP3, compared to about 10–30% of those with herpes zoster, ~10–25% of diabetic neuropathy and ~10% with stroke4,5,6. In our recent nationwide survey of patients with spinal cord-related pain syndrome, we introduced the term spinal cord-related pain syndrome to define chronic NeP associated with spinal cord damage, and reported its prevalence to be highest in patients with cervical spondylotic myelopathy, followed by spinal cord injury (SCI) and cervical spine ossification of longitudinal ligament (OPLL)7. In another multi-center study, we found significantly lower SF-36 scores in patients with spinal cord-related pain syndrome relative to the national average8. Our findings suggest that chronic NeP affects the physical and functional status, as well as the mental health and activities of daily living9,10, and that the management of chronic NeP requires a multidisciplinary approach.
While the underlying mechanisms of chronic NeP are multifactorial and change with time, spinal and supraspinal lesions are the main mechanisms of NeP. Whereas several studies analyzed the pathomechanism of NeP after SCI, little is known about these mechanisms in patients with compressive myelopathy. Evidence suggests that monocytes, macrophages, and especially glial cells may play important roles in chronic NeP associated with compressive myelopathy11. The microglia-specific molecules, P2X purinoceptor 4 (P2X4) and p38 mitogen-activated protein kinases (p38 MAPKs), are upregulated and activated in NeP after peripheral nerve injury12,13,14. In this context, we reported previously that transplantation of bone marrow-derived mesenchymal stem cells (BMSC) reduced NeP after SCI by suppressing the expression levels of PKC-γ, p-CREB, p-p38 MAPK, and p-ERK1/2 in dorsal horn neurons and restoring abnormal blood-spinal cord barrier (BSCB), mediated through modulation of spinal-resident microglia and hematogenous macrophages activity and recruitment15. However, there is no information on the effects of progressive compression of the spinal cord on NeP-related pathological changes, such as glial activation and BSCB dysfunction. In this regard, our group published a series of studies conducted in mice with spontaneous spinal cord compression (tip-toe walking mouse (ttw/ttw)). Some of the main findings of these studies included a profound decrease in the number of neurons in the anterior horn (which correlated with the extent of spinal cord compromise) and increased number of glial cells in both the gray and white matters16.
The present study was designed to explore the potential mechanism of NeP in chronic progressive compressed spinal cord using ttw/ttw mouse. Specifically, we analyzed the status of microglia/macrophage accumulation and MAPK signaling in the compressed areas. Furthermore, we used chimeric ttw/ttw mice. The bone marrow of this mouse contains green fluorescent protein (GFP)-expressing hematogenous cells. We determined the pathological roles of cervical spinal microglia and macrophages of bone marrow origin in NeP associated with long-term spinal cord compression.
Results
MRI assessment of progressive compression of the spinal cord
Serial analysis showed age-related increase in the severity of spinal cord compression in the ttw/ttw mice at the C1-C2 vertebral level; the calcified mass increased in size with age particularly in the atlantoaxial membrane posteriorly. Quantitative analysis of the MRI images and H&E stained sections demonstrated a significant age-related decrease in the C1-C2 spinal cord transverse area, relative to that at the Th1 vertebral level: 0.81 ± 0.09 in 12-week-old, 0.63 ± 0.17 in 18-week-old, 0.34 ± 0.05 in 24-week-old ttw/ttw mice (Fig. 1). The above results demonstrated a close correlation between MRI and histological findings.
Mechanical allodynia and thermal sensitivity in ttw/ttw mice
The threshold of mechanical and thermal sensitivity scores were significantly lower in ttw/ttw mice compared with ICR mice at 18- and 24-weeks of age (Fig. 2). In the present study, allodynia was tested in 139 ttw/ttw mice and 108 (77.7%) of these mice were chosen for the test based on the presence of significant sensory differences at 18- and 24-weeks of age relative to the ICR mouse.
Expression of GFP in spinal cord of bone marrow-chimeric ttw/ttw mice
To determine whether the bone marrow-derived cells are recruited into the chronically compressed spinal cord, chimeric ttw/ttw mice were prepared with GFP-labeled hematogenous cells. GFP-positive cells increased significantly in proportion with the degree of spinal cord compression, especially in 18- and 24-week-old mice. There were few GFP-positive cells in ICR and 12-week-old mice (Fig. 3).
Immunostaining of transverse sections of the spinal cord of ttw/ttw mice showed a proportionate increase in the number of CD11b positive cells in the dorsal horn with the degree of spinal cord compression. Dual-labeled cells for CD11b and GFP also increased proportionately with the degree of spinal cord compression and the proportion of CD11b and GFP dual labeled cells was high among CD11b-positive cells (Fig. 4). Figure 4M shows the number of activated microglia (CD11b-positive/GFP-negative cells) and hematogenous macrophages (CD11b-positive/GFP-positive cells) in the dorsal horn. The percentage of hematogenous macrophages among CD11b-positive cells increased significantly from 51.3 ± 3.9% in 18-week-old to 80.3 ± 8.7% in 24-week-old ttw/ttw mice.
To examine the recruitment of hematogenous macrophage into the chronic compressed spinal cord, GFP+/CD45+/CD11b+/Gr-1− cells were quantified by flow cytometric analysis. The number of GFP+/CD45+/CD11b+/Gr-1− cells per cross section increased significantly and gradually in the chronically compressed spinal cord of ttw/ttw mice from 100 ± 24 in 12-week-old, to 509 ± 122 in 18-week-old and 2512 ± 578 in 24-week-old mouse (Fig. 5).
Expression of MAPK-positive cells in dorsal horn
Chronic spinal cord compression in ttw/ttw mice was associated with increases in dually labeled p-p38 MAPK/GFP and p-ERK1/2/GFP cells within the spinal cord dorsal horn (Figs 6 and 7). The number of p-p38-positive cells among GFP-positive cells increased significantly with worsening of spinal cord compression, from 0.67 ± 0.82 in 12-week-old, 20.50 ± 11.52 in 18-week-old, to 34.50 ± 10.05 in 24-week-old ttw/ttw mice (Fig. 6M). A similar trend was noted with p-ERK1/2 cells among GFP-positive cells (from 0.67 ± 0.82 in 12-week-old, 16.67 ± 8.85 in 18-week-old, to 24.67 ± 12.47 in 24-week-old ttw/ttw mouse) (Fig. 7M). The correlation between severity of compression of the spinal cord and p-p38 MAPK and p-ERK1/2 was evaluated by western blotting. The intensities of the p-p38 band increased with age; which were significantly higher at 24 weeks than at 12- and 18 weeks (Figs 6N,O and 7N,O).
Effects of chronic spinal cord compression on BSCB function
In this study, the expression of PDGFR-α, which is localized on perivascular astrocytic endfeet was used as a surrogate marker of BSCB function. PDGFR-α immunoreactivity at the lesion site increased significantly with chronic spinal cord compression from 12 to 18 weeks of age. However, it was lower in 24-week-old, compared with the that in 18-week-old ttw/ttw mice (Fig. 8A–F). Transmission electron microscopy indicated that endothelial cells, pericytes and astrocytic endfeet were the main structures that formed blood vessels in the spinal cord. Although the expression of PDGFR-α increased with spinal cord compression, there was no marked disruption of the vascular structures at the dorsal horn in 18-week-old ttw/ttw mouse (Fig. 8G–I).
Discussion
Little is known about the mechanisms of NeP in chronic progressive spinal cord compression, compared with that of peripheral nerves, especially with regard to the roles of microglial activation and macrophages infiltration. NeP is not just a symptom of disease, but a consequence of disordered functioning of the nervous system11. The pathogenesis of NeP and central sensitization after peripheral nerve injury and traumatic SCI seems to involve spinal cord microglia and macrophages17,18. The aim of this research was to determine the roles of activated microglia and infiltrating macrophages in NeP associated with chronic progressive spinal cord compression. In the present study, GFP-labeled bone marrow chimeric ttw/ttw mice were used to determine the roles of these cells in NeP associated with long-term compression of the spinal cord. The main novel findings of the present study were activated microglia accumulation and macrophage migration from the peripheral circulation into the neural tissue through temporary disruption of the BSCB, together with increased activation of the MAPK signaling pathway. The study showed that these changes varied according to the severity of spinal cord compression, suggesting the involvement of these mechanisms in NeP.
Is the ttw/ttw mouse a suitable animal model for investigating the effects of chronic progressive compression of the spinal cord? The histopathological and pathophysiological changes found in these mice are significantly similar to those usually found in traumatic SCI. They include fewer neuronal cells, degeneration and demyelination of neurons, and various secondary changes. Cadaver studies that examined the spinal cords of patients with cervical spondylosis or OPLL reported that chronic progressive mechanical compression of the spinal cord initially induces hypoxia/ischemia and is characterized by the loss and exfoliation of anterior horn neurons with progressive spongy degeneration and demyelination in the white matter19,20. These changes in turn induce a variety of extracellular and intracellular pro-apoptotic pathways and neuroinflammation. It seems that these cellular changes contribute to the neurological functional deficits and NeP observed in cervical myelopathy21. In a series of studies using the ttw/ttw mouse, we reported previously that severe spinal cord compression correlated significantly with fewer remaining surviving neurons and severe demyelination of the white matter16,22. These findings were similar to those seen in cadaver studies, indicating that the ttw/ttw mouse is an appropriate animal model for investigating the effects of long-term mechanical compression of the spinal cord.
Our study confirmed the roles of activated microglia and macrophages in the pathogenesis of NeP in chronic compression of the spinal cord. Glial cells are considered to play an important role in the maintenance of neuronal function. However, recent studies demonstrated the involvement of these cells in neuroplasticity. In particular, activated microglia and macrophages in the spinal cord are involved in the pathomechanisms of NeP. Recent studies demonstrated that traumatic injury of the neural system, such as SCI, induces neuronal hyperactivity and persistent glial activation, the two important substrates of central NeP23. The activated microglia and recruited macrophages are thought to play important roles in neuroinflammation through the induction/modulation of a wide range of cellular responses24. Neuroinflammation plays an important role in the establishment and maintenance of both NeP and chronic pain. Increased levels of inflammatory cytokines, chemokines and microglial activation contribute to the activation of pain mechanisms; chronic pain is the result of dysregulated glial activation25,26,27. The mechanism of NeP that follows SCI includes activation of various MAPK family members; both p-38 MAPK and ERK are activated in microglia in the spinal dorsal horn, which play a role in the development and persistence of NeP, which enhances central sensitization and long-term potentiation28,29. These kinases play a key role in microglial signaling since the latter can be activated by multiple microglial receptors, and it also regulates the synthesis of many inflammatory mediators associated with pain facilitation. We reported previous study that transplantation of mesenchymal stem cells soon after SCI relieved pain hypersensitivity through inhibition of MAPK signaling pathway and lessened recruitment of inflammatory cells15. Other studies reported that activated microglia play important roles in both hindpaw behavioral sensitivity and lumbar neuronal hyperexcitability via activation of p38 MAPK and ERK1/2 phosphorylation30,31. On the other hand, little is known about the pathomechanism of chronic NeP in patients with compressive myelopathy, especially whether hematogenous macrophages play a role in NeP associated with chronic spinal cord compression. In this study, GFP-labeled bone marrow chimeric ttw/ttw mice were used to determine the relative roles of these cells since activated microglia and macrophages in the injured CNS cannot be distinguished by their morphology or the use of antigenic makers. Our results indicated that the density of activated microglia/macrophage (CD11b+ cells) in the dorsal horn was proportionate with the severity of spinal cord compression, hematogenous macrophages (CD11b and GFP double-positive cells) constituted 51.3% in 18- and 80.3% in 24-week-old ttw/ttw mice of the cells. In addition, many of these macrophages expressed p-38 MAPK and ERK1/2, which are known to play a role in the expression of mechanical allodynia. It is likely that high-dose irradiation plays a negligible role in the disruption of the BSCB since only a few GFP-positive cells were found in ICR and 12-week-old ttw/ttw mice.
Another finding of our study was increased BSCB permeability in the chronically compressed spinal cord. Following SCI, damage to endothelial cells from the resultant ischemia may alter BSCB integrity and influx of inflammatory cells and immunocytes to the inflammatory response site around the site of injury. Thus; the spinal cord microglia and macrophages are probably involved, at least in part, in the pathogenesis of NeP and central sensitization after SCI15. Increased BSCB permeability alters the cellularity of the spinal cord microenvironment and this could further potentiate neuroinflammation32. Little information is available on the mechanisms of BSCB dysfunction and neuroinflammatory responses in animal models with chronically compressed spinal cord. In our study, a significant increase in PDGFR-α immunoreactivity was noted at the lesion site especially in 18-week-old ttw/ttw mice. The results suggest that both chronic compression and traumatic injury of the spinal cord enhance BSCB permeability. Interestingly, marked disruption of the vascular structures of the dorsal horn was not observed in the present study, in contrast to traumatic spinal cord injury. Our results also suggested that the increased BSCB permeability was reversible in our model. A previous study using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) enhancement magnetic resonance imaging showed disruption of the spinal cord parenchyma and disturbance of the BSCB in the injured spinal cord, suggesting that the enhancement disappeared or decreased after surgery in most patients with cervical myelopathy; and that disturbance of BSCB in chronic compression can be reversible33.
In summary, the results of this study suggested that progressive long-term spinal cord compression sets up a chain of events characterized by macrophage migration from the peripheral circulation into the neural tissue through temporary disruption of the BSCB as well as increased microglia activation, which was proportionate with the severity of compression. These results suggest that NeP is mediated through these histopathological changes. Our findings are potentially useful for the design of new therapies that can alleviate NeP by reducing neuroinflammation through the suppression of microglial activation and/or macrophage migration.
Methods
All methods in this study were performed in accordance with the relevant institutional guidelines and regulations.
Animals
The study was conducted in spinal hyperostotic ttw/ttw mice (12-week-old, n = 37, 18-week-old, n = 37, 24-week-old, n = 34), with a mean body weight of 28.3 ± 1.5 g, purchased from the Central Institute for Experimental Animals (Kawasaki, Japan). Homozygous ttw/ttw mice were naturally occurring mutant mice and maintained by brother-sister mating of heterozygous ICR mice (+/ttw, Clea, Tokyo, Japan). ICR mice of the same age were used as the control group (n = 9). Hyperostosis is induced under an autosomal recessive condition and the homozygous hyperostotic mouse assumes a tip-toe walking pattern at the age of 6–8 weeks, although no congenital neurological abnormalities are detected at that age. In the ttw/ttw mouse, calcified masses appear at the posterior aspects of C1 and C2, causing C2 and C3 cord segment compression with ankylosis. The calcified masses increase in size with age particularly in the atlantoaxial membrane, and often produce extensive motor weakness in 18–24-week-old mice34,35. Adult male mice (age 6–8 weeks) weighing 19.2 ± 0.6 g show upregulation of enhanced-GFP (EGFP), which is induced by CAG (cytomegalovirus early enhancer β-actin) transgene (CAG-EGFP mice; Nihon SLC, Shizuoka, Japan).
Following institutional ethical review and approval (The Institutional Animal Care and Use Committees of Fukui University, Department of Orthopaedics and Rehabilitation Medicine: Approval Number 23–002) and the Ethical Guidelines of the International Association for the Study of Pain, all mice were handled carefully to lessen any chance of pain or discomfort.
Hematoxylin and eosin staining
The cervical spine (n = 5 for each time point) was resected carefully as described previously and then fixed in buffered formaldehyde for 48 hours at 4 °C34. Later, the obtained tissue was decalcified in 0.5 M ethylenediaminetetraacetic acid (0.5 M Tris-HCl buffer, pH 7.6) over a period of 2 weeks at 4 °C. The sections were embedded in paraffin and later cut into 20-µm-thick sagittal and axial sections using a cryostat, which were then stained with hematoxylin and eosin (H&E).
Assessment of progressive compression of spinal cord with MRI
The severity of compression of the cervical spine was assessed by measuring the spinal canal area using 7T-magnetic resonance imaging (MRI) (BioSpec®, Bruker biospin, Billerica, MA) in anesthetized animals. The obtained images were assayed using Image J analysis software (NIH, Bethesda, MD). The analyzed the correlation between age and spinal canal area measured at the most severe level of compression in the C1-C2 region. Furthermore, modifying the methods as described previously16, the spinal canal areas at C1 and C2 were compared with that of thoracic (Th) 1 vertebra.
Sensory testing
Two independent examiners (S.W. and K.H.) who were blinded to the experimental condition in order to avoid any bias tested the mice at different ages (12, 18, and 24 weeks) for mechanical allodynia and thermal sensitivity. The former was tested by the Dynamic Plantar Aesthesiometer (Ugo Basile, Comerio, Italy)36. In this test, the withdrawal threshold (expressed in grams) is determined five times and the mean value is reported. The independent examiners also tested for thermal sensitivity at the plantar hindpaws using the Plantar Test Apparatus (Ugo Basile), as described in detail previously37. In this test, the time between application of the thermal stimulus to hindpaw withdrawal (latency) is recorded (in sec), as well as any other reaction to the stimulus (e.g., gazing at the affected paw, sniffing, licking, or attacking the stimulus). The latency was calculated using data of six tests after rejecting the longest and shortest latencies, as described previously by Hoschouer et al.38.
Bone marrow-chimeric ttw/ttw mice
The bone marrow-chimeric ttw/ttw mice was generated using highly purified, genetically marked bone marrow cells, as described in detail elsewhere15,17,39. Isolated unfractionated marrow cells (5.0 × 106 cells) were obtained from the donor mice (CAG-EGFP transgenic mice) and injected into the tail vein of previously irradiated 9-, 14- and 20-week-old ttw/ttw and ICR mice (dose: 9.0 Gy over 30 min, 4.5 Gy/15 min twice). Engraftment and induction of chimerism was confirmed by identifying the donor cells 3–4 weeks later by FACS Calibur (Dual-laser Fluorescence-Activated Cell Sorting, BD Biosciences, San Jose, CA). Subsequent experiments were conducted in 12-, 18- and 24-week-old bone marrow chimeric mice.
Immunohistochemistry
For immunohistochemical analysis, the mouse was deeply anesthetized (n = 5/time point), transcardially perfused and the obtained tissues were fixed with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS). Similarly, the spinal cord was dissected out carefully and kept in a similar fixative. After 3 hours in the fixative solution, the tissue samples were immersed in a mixture of 10% sucrose/0.1 M PBS and maintained at 4 °C for 24 hours, and then in another solution of 20% sucrose/0.1 M PBS for another 24 hours. On the other hand, the cervical area of the spinal cord was embedded in OCT (optimal cutting temperature) compound (Sakura Finetek, Torrance, CA) and then cut into serial 20 µm-thick axial or sagittal frozen sections using a cryostat. The cut sections were serially mounted on glass slides and fixed for 5 min with 2% paraformaldehyde in 0.1 M PBS, followed by rinsing in PBS and storage under cold temperature (−80 °C).
The immunohistochemical staining continued with permeabilization of the frozen sections with 0.1 M Tris-HCl buffer (with 0.3% Triton X-100, pH of 7.6). The sections were treated overnight with following primary antibodies (Abs) at 4 °C, which were diluted with the Antibody Diluent with Background Reducing Components (Dako Cytomation, Carpinteria, CA): rabbit anti-phospho-p38 MAP kinase (p-p38) polyclonal Ab (dilution, 1:200, Cell Signaling Technology, Beverly, MA); rabbit anti- p44/42 MAPK (p-ERK1/2) polyclonal Ab, 1:200 (Cell Signaling Technology); rabbit anti-integrin αM (or CD11b), 1:200 (Santa Cruz Biotechnology, Santa Cruz, CA). The sections were then incubated with Alexa Fluor-conjugated 488- or 568- secondary antibodies (dilution, 1:250, Molecular Probes, Eugene, OR) for 1 hr at room temperature. Finally, the sections were washed, wet-mounted, and examined by omitting the primary antibody or through the use of a non-specific negative isotype-matched primary antibody, as described previously16. The sections were examined under a fluorescence microscope (Olympus AX80, 200 Olympus Optical, Tokyo) or confocal laser scanning microscope (model TCS SP2, Leica Instruments, Nussloch, Germany), using 488- and 543-nm lines of the argon/helium-neon laser for fluorescence excitation.
Semi-quantitative analysis
At 12, 18, and 24 weeks of age, five axial sections were randomly selected from the site of maximum compression (between C2 and C3 dorsal roots) and half of the spinal cord on the compressed side, to determine the density of GFP+ cells, CD11b+/GFP+ cells, and p-38 MAPK+ and p-ERK1/2+ colocalized with GFP+ cells in the superficial laminae I-III of the spinal dorsal horn. For PDGFR-α staining, we calculated the area and pixel density within the immunoreactivity threshold value in the superficial laminae I-III of spinal dorsal horn on the compressed site, as described previously2. The calculated immunopositivity represented the pixel density multiplied by image area. The latter was determined using the color image analyzer (MacSCOPE; Mitani, Fukui, Japan).
Flow cytometric analysis
Flow cytometric analysis was conducted as described previously15 using tissues harvested from 2.5 mm on either side of the site of spinal cord compression in 12-, 18- and 24-week-old bone marrow chimeric mice. Before immunostaining for flow cytometry, cell-count was performed in each sample in order to ensure cell concentration at 1.0 × 106 cells/100 µl. Hematogenous macrophages represented GFP+ CD45high CD11bhigh GR-1− cells while endogenous activated microglia represented GFP− CD45high CD11bhigh GR-1− cells, as described previously40. After sorting GFP-positive cells, intracellular staining was performed as described in detail previously41. Briefly, the harvested cells were resuspended in fixation buffer and then treated with permeabilization buffer (Santa Cruz Biotechnology, Santa Cruz, CA). They were then re-suspended in ice-cold PBS and incubated with one of the following Abs: 0.25 µg/1 ml PerCP-CyTM 5.5 rat anti-CD11b Ab (BD Pharmingen, San Jose, CA), 0.25 µg/1 ml allophycocyanin (APC) rat anti-CD45 Ab (BioLegend, San Diego, CA), and 1.0 µg/1 ml Pacific BlueTM rat anti-Ly-6G/Ly-6C Ab (Gr-1, BioLegend), each for 1 hr. Flow cytometry was then performed using FACS CantoTM II (BD Biosciences) with forward scattering to eliminate any cellular debris.
Immunoblot analysis
For immunoblot analysis, the spinal cord was carefully dissected en bloc from the area of greatest compression (located between the exit of C2-C3 dorsal roots) (n = 3 mice/each time point) and stored at −80 °C, as described previously16. The sections were centrifuged at 15,000 × g for 30 sec (BioMasher Rapid Homogenization Kit, Funakoshi, Tokyo), then solubilized in RIPA lysis buffer 1 × (Santa Cruz Biotechnology), homogenized and stored at −80 °C. To determine the protein concentration in the tissue samples, we used the DC protein assay kit (Bio-Rad Laboratories, Hercules, CA) according to Lowry protein Assay. The protein mixtures were mixed with Laemmli sodium dodecylsulfate buffer and boiled prior to immunoblot analysis. The total protein (20 µg/lane) was separated on 12.5% SDS-PAGE and transferred onto polyvinylidene difluoride membrane (PE Applied Biosystems, Foster, CA) for 70 min. The membranes were washed twice in PBS solution containing 0.05% Tween 20, then blocked by a mixture of 5% skimmed milk in PBS for 1 hr at room temperature, and finally incubated overnight with one of the following antibodies at 4 °C: rabbit anti-phospho-p38 MAP kinase (p-p38) polyclonal Ab or rabbit anti- p44/42 MAPK (ERK/2) polyclonal Ab (each diluted at 1:200, and both from Cell Signaling Technology, Danvers, MA); or rabbit anti-platelet-derived growth factor receptor-α (PDGFR-α) polyclonal Ab (dilution, 1:200, Santa Cruz Biotechnology). After washing three times in 0.1 M PBS, the membranes were incubated for 1 hr in the respective secondary IgG/HRP complex Abs: anti-goat (dilution, 1:1,000); anti-rabbit (dilution, 1:5,000); or anti-rat (dilution, 1:1,000) (all from Santa Cruz Biotechnology). After washing three times in 0.1 M PBS, the membranes were immersed in ECL Advance Western Blot Detection kit (GE Healthcare, Buckinghamshire, UK) for 1 min and examined with imaging analyzer (Image Quant LAS 4000 mini chemiluminescence, GE Healthcare Life Science, Piscataway, NJ). The intensity of each band was quantified using Image Quant TL software (GE Healthcare Life Science) and expressed relative to that of β-actin. For molecular weight controls, we used the Kaleidoscope Prestained Standards (Bio-Rad Laboratories, Hercules, CA).
Electron microscopy
Tissues harvested from 12- and 18-week-old ttw/ttw mice were used for electron microscopic examination. Briefly, the mouse was euthanized by deep anesthesia, then fixed with 2.5% glutaraldehyde and 2.5% paraformaldehyde, then fixed with 1% osmium tetroxide for 2 hrs. The spinal cord area around the site of maximum compression was removed and the fixed specimens were dehydrated in a graded series of alcohol, embedded in epoxy resin and polymerized at 60 °C for 2 days. Ultrathin sections were obtained using an ultramicrotome and stained with uranyl acetate and lead citrate. Finally, images were prepared using a transmission electron microscope (model H-7650 TEM; Hitachi, Tokyo).
Statistical analysis
All values are expressed as mean ± SD. Differences between groups were tested for statistical significance using one-way analysis of variance (ANOVA). The p value determined by Tukey’s post hoc analysis was set to <0.05. For measurement of stained tissues, the inter- and intra-observer reliability was assessed by calculating intraclass correlation coefficients (ICC), and ICC values < ± 0.75–1.00 were considered to represent excellent reliability. All statistical tests were performed using SPSS software version 24.0 (SPSS, Chicago, IL).
Data availability
Data generated and analyzed during this study are included in this published article. Data and materials are available from the corresponding author subject to reasonable request and subject to the ethical approvals in place and materials transfer agreements.
References
Merskey, H. & Bogduk, N. Classification of Chronic Pain. Second ed. IASP Press. Seattle (1994).
Treede, R. D. et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 70, 1630–1635 (2008).
Yamashita, T., Takahashi, K., Yonenobu, K. & Kikuchi, S. Prevalence of neuropathic pain in cases with chronic pain related to spinal disorders. J Orthop Sci. 19, 15–21 (2014).
Davies, M., Brophy, S., Williams, R. & Taylor, A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 29, 1518–1522 (2006).
Sadosky, A., McDermott, A. M., Brandenburg, N. A. & Strauss, M. A review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Pract. 8, 45–56 (2008).
Van Acker, K. et al. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics. Diabetes Metab. 35, 206–213 (2009).
Nakajima, H. et al. Multicenter cross-sectional study of the clinical features and types of treatment of spinal cord-related pain syndrome. J Orthop Sci. 24, 798–804 (2019).
Nakajima, H., Uchida, K., Takayasu, M., Ushida, T. Nationwide survey of spinal cord-related pain syndrome in Japan: Clinical characteristics and treatment. Spine Surg Relat Res. in press (2019).
Doth, A. H., Hansson, P. T., Jensen, M. P. & Taylor, R. S. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 149, 338–344 (2010).
Inoue, S. et al. The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population. Eur J Pain. 21, 727–737 (2017).
Tsuda, M. Microglia in the CNS and Neuropathic Pain. Adv Exp Med Biol. 1099, 77–91 (2018).
Inoue, K. Role of the P2X4 receptor in neuropathic pain. Curr Opin Pharmacol. 47, 33–39 (2019).
Jin, S. X., Zhuang, Z. Y., Woolf, C. J. & Ji, R. R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci. 23, 4017–4022 (2013).
Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 424(6950), 778–783 (2003).
Watanabe, S. et al. Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment. Stem Cells. 33, 1902–1914 (2015).
Hirai, T. et al. The prevalence and phenotype of activated microglia/macrophages within the spinal cord of the hyperostotic mouse (twy/twy) changes in response to chronic progressive spinal cord compression: implications for human cervical compressive myelopathy. PLoS One. 8, e64528, https://doi.org/10.1371/journal.pone.0064528 (2013).
Isami, K. et al. Involvement of TRPM2 in peripheral nerve injury-induced infiltration of peripheral immune cells into the spinal cord in mouse neuropathic pain model. PLoS One. 30, e66410, https://doi.org/10.1371/journal.pone.0066410 (2013).
Zhang, J. et al. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci. 7, 12396–12406 (2007).
Kameyama, T. et al. Spinal cord morphology and pathology in ossification of the posterior longitudinal ligament. Brain. 118, 263–278 (1995).
Mizuno, J., Nakagawa, H., Iwata, K. & Hashizume, Y. Pathology of spinal cord lesions caused by ossification of the posterior longitudinal ligament, with special reference to reversibility of the spinal cord lesion. Neurol Res. 14, 312–314 (1992).
Dolan, R. T., Butler, J. S., O’Byrne, J. M. & Poynton, A. R. Mechanical and cellular processes driving cervical myelopathy. World J. Orthop. 7, 20–29 (2016).
Inukai, T. et al. Tumor necrosis factor-alpha and its receptors contribute to apoptosis of oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy) sustaining chronic mechanical compression. Spine (Phila Pa 1976). 34, 2848–2857 (2009).
Gwak, Y. S., Kang, J., Unabia, G. C. & Hulsebosch, C. E. Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats. Exp Neurol. 234, 362–372 (2012).
Hausmann, O. N. Post-traumatic inflammation following spinal cord injury. Spinal Cord. 41, 369–378 (2013).
Carniglia, L. et al. Neuropeptides and microglial activation in inflammation, pain, and neurodegenerative diseases. Mediators Inflamm. 2017, 5048616, https://doi.org/10.1155/2017/5048616 (2017).
Ramesh, G., MacLean, A. G. & Philipp, M. T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm. 2013, 480739, https://doi.org/10.1155/2013/480739 (2013).
Zhang, Z. J., Jiang, B. C. & Gao, Y. J. Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain. Cell Mol Life Sci. 74, 3275–3291 (2017).
Inoue, K. & Tsuda, M. Microglia in neuropathic pain: cellular and molecular mechanisms and therapeutic potential. Nat Rev Neurosci. 19, 138–152 (2018).
Tsuda, M. et al. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia. 45, 89–95 (2004).
Hains, B. C. & Waxman, S. G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci. 19, 4308–4317 (2006).
Zhao, P., Waxman, S. G. & Hains, B. C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci. 27, 2357–2368 (2007).
Guerrero, A. R. et al. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation. 9, 40 (2012).
Ozawa, H. et al. Clinical significance Gd-DTPA cervical myelopathy. Spinal Cord. 48, 415–422 (2010).
Uchida, K. et al. Apoptosis of neurons and oligodendrocytes in the spinal cord of spinal hyperostotic mouse (twy/twy): possible pathomechanism of human cervical compressive myelopathy. Eur Spine J. 21, 490–497 (2012).
Yu, W. R. et al. Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: Implications for the pathophysiology of human cervical spondylotic myelopathy. Neurobiol Dis. 33, 149–163 (2009).
Martucci, C. et al. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain. 137, 81–95 (2008).
Hargreaves, K. et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32, 77–88 (1988).
Hoschouer, E. L., Basso, D. M. & Jakeman, L. B. Aberrant sensory responses are dependent on lesion severity after spinal cord contusion injury in mice. Pain. 148, 328–342 (2010).
Koide, Y. et al. Two distinct stem cell lineages in murine bone marrow. Stem Cells. 25, 1213–1221 (2007).
Saiwai, H. et al. The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am J Pathol. 176, 2352–2366 (2010).
Stirling, D. P. & Yong, V. W. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res. 86, 1944–1958 (2018).
Acknowledgements
This study was supported by three grants-in-aid for Scientific Research (#JP15K10391, #JP16K10817, #19K09645). This work was also supported in part by grants from the Investigation Committee on Ossification of the Spinal ligaments, the Public Health Bureau of the Japanese Ministry of Labor, Health and Welfare.
Author information
Authors and Affiliations
Contributions
N.T. and H.N. designed various aspects of the study. N.T., H.N. and A.M. wrote the final manuscript text, N.T., H.N., S.W. and K.H. prepared Figures 1 and 2. N.T. and A.T. prepared Figures 3, 4, 6 and 7. N.T. and K.H. prepared Figure 4. N.T. and H.N. prepared Figure 8. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Takeura, N., Nakajima, H., Watanabe, S. et al. Role of macrophages and activated microglia in neuropathic pain associated with chronic progressive spinal cord compression. Sci Rep 9, 15656 (2019). https://doi.org/10.1038/s41598-019-52234-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-52234-1
- Springer Nature Limited
This article is cited by
-
Flow cytometry analysis of immune and glial cells in a trigeminal neuralgia rat model
Scientific Reports (2021)
-
Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?
Journal of Neuroimmune Pharmacology (2021)